These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 28017231)

  • 1. An AOA2 patient with a novel compound heterozygous SETX frame shift mutations.
    Motokura E; Yamashita T; Takahashi Y; Tsunoda K; Sato K; Takemoto M; Hishikawa N; Ohta Y; Hashiguchi A; Takashima H; Abe K
    J Neurol Sci; 2017 Jan; 372():294-296. PubMed ID: 28017231
    [No Abstract]   [Full Text] [Related]  

  • 2. "Pseudodominant inheritance" of ataxia with ocular apraxia type 2 (AOA2).
    Schöls L; Arning L; Schüle R; Epplen JT; Timmann D
    J Neurol; 2008 Apr; 255(4):495-501. PubMed ID: 18350359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory radiculoneuropathy in an ALS4 patient with a novel SETX mutation.
    Saiga T; Tateishi T; Torii T; Kawamura N; Nagara Y; Shigeto H; Hashiguchi A; Takashima H; Honda H; Ohyagi Y; Kira J
    J Neurol Neurosurg Psychiatry; 2012 Jul; 83(7):763-4. PubMed ID: 22577233
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutation of senataxin alters disease-specific transcriptional networks in patients with ataxia with oculomotor apraxia type 2.
    Fogel BL; Cho E; Wahnich A; Gao F; Becherel OJ; Wang X; Fike F; Chen L; Criscuolo C; De Michele G; Filla A; Collins A; Hahn AF; Gatti RA; Konopka G; Perlman S; Lavin MF; Geschwind DH; Coppola G
    Hum Mol Genet; 2014 Sep; 23(18):4758-69. PubMed ID: 24760770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Molecular Aspects of Senataxin Mutations in Amyotrophic Lateral Sclerosis 4.
    Grunseich C; Patankar A; Amaya J; Watts JA; Li D; Ramirez P; Schindler AB; Fischbeck KH; Cheung VG
    Ann Neurol; 2020 Apr; 87(4):547-555. PubMed ID: 31957062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An autopsy case of sporadic, adult-onset amyotrophic lateral sclerosis with heterozygous p.N1935S SETX gene variant.
    Nakamura M; Nishii M; Kume K; Kawakami H; Yakushiji Y
    J Neuropathol Exp Neurol; 2023 Jul; 82(8):734-738. PubMed ID: 37280161
    [No Abstract]   [Full Text] [Related]  

  • 7. Senataxin: A key actor in RNA metabolism, genome integrity and neurodegeneration.
    Giannini M; Porrua O
    Biochimie; 2024 Feb; 217():10-19. PubMed ID: 37558082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some pathogenic SETX variants are partially conserved during evolution.
    Tariq H; Tariq I; Bourinaris T; Houlden H; Naz S
    Gene; 2021 Mar; 771():145360. PubMed ID: 33333218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening of the SETX gene in sporadic amyotrophic lateral sclerosis patients of Chinese origin].
    Zhang H; Liang JL; Chen SY; Wang ZJ; Yang F; Cui F; Ren YT; Liu WX; Sun ZS; Huang XS
    Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(33):2628-2631. PubMed ID: 30220148
    [No Abstract]   [Full Text] [Related]  

  • 10. A SUMO-dependent interaction between Senataxin and the exosome, disrupted in the neurodegenerative disease AOA2, targets the exosome to sites of transcription-induced DNA damage.
    Richard P; Feng S; Manley JL
    Genes Dev; 2013 Oct; 27(20):2227-32. PubMed ID: 24105744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autosomal recessive ataxia with peripheral neuropathy and elevated AFP: novel mutations in SETX.
    Asaka T; Yokoji H; Ito J; Yamaguchi K; Matsushima A
    Neurology; 2006 May; 66(10):1580-1. PubMed ID: 16717225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Senataxin mutations and amyotrophic lateral sclerosis.
    Hirano M; Quinzii CM; Mitsumoto H; Hays AP; Roberts JK; Richard P; Rowland LP
    Amyotroph Lateral Scler; 2011 May; 12(3):223-7. PubMed ID: 21190393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare phenotype of ALS4 associated with heterozygous missense mutation c.5842A > G/p.M1948V in helicase domain of
    Andreini I; Moro F; Africa LM; Rubegni A; Santorelli FM; Scarpini C; Sicurelli F; Battisti C
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 May; 21(3-4):312-313. PubMed ID: 32186211
    [No Abstract]   [Full Text] [Related]  

  • 14. Altered translational repression of an RNA-binding protein, Elav by AOA2-causative Senataxin mutation.
    Choudhury SD; Vs A; Mushtaq Z; Kumar V
    Synapse; 2017 May; 71(5):. PubMed ID: 28245518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new SETX mutation producing AOA2 in two siblings.
    Datta N; Hohler A
    Int J Neurosci; 2013 Sep; 123(9):670-3. PubMed ID: 23566282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular findings of ataxia with oculomotor apraxia type 2 (AOA2) in 5 Tunisian families.
    Hammer MB; El Euch-Fayache G; Nehdi H; Saidi D; Nasri A; Nabli F; Bouhlal Y; Maamouri-Hicheri W; Hentati F; Amouri R
    Diagn Mol Pathol; 2012 Dec; 21(4):241-5. PubMed ID: 23111195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two novel mutations of the SETX gene and ataxia with oculomotor apraxia type 2.
    Pera J; Lechner S; Biskup S; Strach M; Grodzicki T; Slowik A
    Clin Neurol Neurosurg; 2015 Jan; 128():44-6. PubMed ID: 25462094
    [No Abstract]   [Full Text] [Related]  

  • 18. Mutation in the senataxin gene found in a patient affected by familial ALS with juvenile onset and slow progression.
    Avemaria F; Lunetta C; Tarlarini C; Mosca L; Maestri E; Marocchi A; Melazzini M; Penco S; Corbo M
    Amyotroph Lateral Scler; 2011 May; 12(3):228-30. PubMed ID: 21438761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Senataxin suppresses the antiviral transcriptional response and controls viral biogenesis.
    Miller MS; Rialdi A; Ho JS; Tilove M; Martinez-Gil L; Moshkina NP; Peralta Z; Noel J; Melegari C; Maestre AM; Mitsopoulos P; Madrenas J; Heinz S; Benner C; Young JA; Feagins AR; Basler CF; Fernandez-Sesma A; Becherel OJ; Lavin MF; van Bakel H; Marazzi I
    Nat Immunol; 2015 May; 16(5):485-94. PubMed ID: 25822250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel SETX variants in a patient with ataxia, neuropathy, and oculomotor apraxia are associated with normal sensitivity to oxidative DNA damaging agents.
    Vantaggiato C; Cantoni O; Guidarelli A; Romaniello R; Citterio A; Arrigoni F; Doneda C; Castelli M; Airoldi G; Bresolin N; Borgatti R; Bassi MT
    Brain Dev; 2014 Sep; 36(8):682-9. PubMed ID: 24183476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.